M H Raitt
- Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trialMerritt H Raitt
Portland VA Medical Center, Oregon Health and Science University, Portland, Oregon, USA
Am J Cardiol 91:812-6. 2003..These findings suggest there are important differences in the electrophysiologic characteristics of these 2 patient populations...
- Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trialMerritt H Raitt
Oregon Health and Science University, Portland, USA
JAMA 293:2884-91. 2005..Clinical studies of omega-3 polyunsaturated fatty acids (PUFAs) have shown a reduction in sudden cardiac death, suggesting that omega-3 PUFAs may have antiarrhythmic effects...
- Predicting imminent episodes of ventricular tachyarrhythmia using heart rateTran Thong
Department of Biomedical Engineering, Oregon Health and Science University, Beaverton, Oregon 97006 8921, USA
Pacing Clin Electrophysiol 30:874-84. 2007..A reliable predictor of an imminent episode of ventricular tachyarrhythmia that could be incorporated in an implantable defibrillator capable of preventive therapy would have important clinical utility...
- Home use of automated external defibrillators for sudden cardiac arrestGust H Bardy
Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
N Engl J Med 358:1793-804. 2008..Consequently, home use of an automated external defibrillator (AED) might offer an opportunity to improve survival for patients at risk...
- Implantable cardioverter-defibrillator shocks: a double-edged sword?Merritt H Raitt
J Am Coll Cardiol 51:1366-8. 2008
- Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversionM H Raitt
Division of Cardiology, Portland Veterans Administration Medical Center, Oregon 97207, USA
Pacing Clin Electrophysiol 23:259-65. 2000..The poor predictive value in patients taking antiarrhythmics may be due to changes in the atrial refractory period, which are not reflected in P wave duration...
- Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) studyMerritt H Raitt
Portland VA Medical Center, Oregon Health and Science University, Portland, OR, USA
Am Heart J 151:390-6. 2006..The early recurrence of atrial fibrillation (AF) after cardioversion and the need for frequent cardioversions to maintain sinus rhythm are important clinical features of AF management...
- Have increasing rates of defibrillator implantation reduced the incidence of out-of-hospital cardiac arrest?Merritt H Raitt
Portland VA Medical Center, Portland, Oregon, USA
Heart Rhythm 1:260-1. 2004
- Reversal of electrical remodeling after cardioversion of persistent atrial fibrillationMerritt H Raitt
Division of Cardiology, Portland VA Medical Center, Portland, Oregon, USA
J Cardiovasc Electrophysiol 15:507-12. 2004..There is limited information on changes in these parameters after cardioversion in patients with persistent atrial fibrillation...
- Electrophysiologic predictors of the recurrence of persistent atrial fibrillation within 30 days of cardioversionMerritt H Raitt
Portland Veterans Affairs Medical Center, Portland, Oregon 97239, USA
Am J Cardiol 93:107-10. 2004..These findings highlight the role of slow conduction and premature atrial contractions in the pathophysiology of atrial fibrillation and suggest a possible proarrhythmic effect of reverse remodeling...
- Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole
Division of Cardiology, University of Washington School of Medicine, 1959 NE Pacific St, Box 356422, Seattle, WA 98195 6422, USA
N Engl J Med 359:1009-17. 2008..e., prevention of a first life-threatening arrhythmic event) may later receive therapeutic shocks from the ICD. Information about long-term prognosis after ICD therapy in such patients is limited...
- Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trialMichael A Brodsky
Division of Cardiology, University of California Irvine Medical Center, Orange, Calif 92868 4080, USA
Am Heart J 144:478-84. 2002..We sought to determine the value of electrophysiology (EP) testing in patients with ventricular fibrillation (VF), ventricular tachycardia (VT) with syncope, or sustained VT in the setting of left ventricular dysfunction...
- "Stable" ventricular tachycardia is not a benign rhythm : insights from the antiarrhythmics versus implantable defibrillators (AVID) registryM H Raitt
Portland VA Medical Center, Portland, Ore, USA
Circulation 103:244-52. 2001..Implantable cardioverter-defibrillator therapy may be indicated in patients presenting with stable VT...
- No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Joseph A Blatt
Department of Cardiology, University of Washington, Box 356422, 1959 NE Pacific Street, Seattle, Washington 98195, USA
J Am Coll Cardiol 52:551-6. 2008..This study investigated whether defibrillation threshold (DFT) testing during implantable cardioverter-defibrillator (ICD) implantation predicts clinical outcomes...
- Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) TrialRichard C Klein
Cardiology Division, University of Utah Health Sciences Center and VA Medical Center, 50 N Medical Drive, Salt Lake City, UT 84132, USA
J Cardiovasc Electrophysiol 14:940-8. 2003..Arrhythmia recurrence rates in these patients are high, but which patients will receive a therapy and the forms of arrhythmia recurrence (VT or VF) are poorly understood...
- Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarctionHarry P Selker
Center for Cardiovascular Health Services Research, Division of Clinical Care Research, Department of Medicine, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
Am J Cardiol 91:280-6. 2003..Those with prolonged QTc or substantial ST elevation who survive the initial 1.5-hour period are those less susceptible to these risks...